Potassium channel blockers

Mar 10, 2020

AltaThera Pharmaceuticals Announces FDA Approval for New Indications of Sotalol IV: A New and Faster Way to Initiate Sotalol Therapy for Atrial Fibrillation (AFib) Patients

Dec 18, 2019

ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL

Oct 31, 2019

ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias

Jan 09, 2019

Pii to Manufacture FDA-approved Bretylium Tosylate Injection Drug Product

Dec 04, 2018

China Glimepiride Market Report, 2013-2022 - Focus on the Third-Generation Sulfonylurea Insulin Secretagogue

Nov 01, 2018

China Repaglinide Market report, 2018-2022: Disease Situation, Market Size, Manufacturers, Competition, Retail Prices & Market Prospects

Sep 26, 2018

China's Gliclazide Market 2018-2022: Sales Value of Gliclazide Kept Rising After the Drug Entered China, and Exceeded CNY 200 Million in 2017

Feb 08, 2018

Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation